Pan-Viral ACTIONS Initiative

Target Audience

This educational initiative is intended for addiction-services providers: MDs, NPs, PAs, counselors, nurses, case managers, peer educators, and nonclinical office staff.

Program Overview

Patients with substance use disorder (SUD), particularly people who inject drugs (PWID), are at increased risk for contracting HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV). A key measure to diagnosing people and mitigating infection spread in the population is testing, ideally pan-viral screening of all 3 infections at once, or triple screening. SUD center providers can play a significant role in triple screening. Point-of-care rapid tests are available for HIV and HCV, and HBV testing can be performed in a laboratory. This educational activity will broaden SUD Center/Addiction Services providers’ understanding of the importance of triple screening, review guidelines on testing and available tests, provide guidance identifying where triple screening fits into a clinic’s workflow, and prepare staff to refer patients in need of treatment or additional prevention measures.

Educational Objectives 

After completing this activity, the participant should be better able to:

• Define current screening guidelines for HIV, HCV, and HBV, including for people at high risk
• Identify optimal community- and clinic-specific strategies to efficiently conduct pan-viral screening for HIV, HCV, and HBV
• Establish linkage to care pathways for patients who require follow-up for HIV, HCV, or HBV treatment or prevention              

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Integritas Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.

Global Contact Information

For information about the accreditation (ANCC credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the pretest, pass the posttest with an 80% score or higher, and submit an evaluation form.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Integritas Communications and Global Education Group (Global) adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  

All relevant financial relationships have been mitigated. 

The faculty have the following relevant financial relationships with ineligible companies:

The planners and managers at Integritas Communications and Global Education Group have no relevant financial relationships to disclose. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.